Murray Korc
- Oncology top 0.05%
- Pancreatic and Hepatic Oncology Research 135
- Cancer Cells and Metastasis 35
- HER2/EGFR in Cancer Research 31
- Cancer Research top 0.1%
- Molecular Biology top 0.1%
- TGF-β signaling in diseases 57
- Fibroblast Growth Factor Research 37
- Metabolism, Diabetes, and Cancer 29
- Cell Biology top 0.2%
- Immunology and Allergy top 0.5%
-
- Pancreatitis Pathology and Treatment 43
- Pancreatic function and diabetes 34
- Co-authors
- Helmut FriessJörg KleeffMarkus W. BüchlerHelmut FrießYoichiro YamanakaToshiyuki IshiwataMarko KornmannMichael S. Kobrin
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Murray Korc
370 papers receiving 26.0k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Oncology 12.3k
- Cancer Research 5.5k
- Molecular Biology 14.7k
- Cell Biology 2.2k
- Immunology and Allergy 784
Countries citing papers authored by Murray Korc
This map shows the geographic impact of Murray Korc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murray Korc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murray Korc more than expected).
Fields of papers citing papers by Murray Korc
This network shows the impact of papers produced by Murray Korc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murray Korc. The network helps show where Murray Korc may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Murray Korc, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 22 | |
| 2 | 2018 | 44 | |
| 3 | 2016 | 93 | |
| 4 | Pathophysiological role of microRNA-29 in pancreatic cancer stroma | 2015 | 2 |
| 5 | 2014 | 8 | |
| 6 | 2013 | 39 | |
| 7 | 2012 | 124 | |
| 8 | 2012 | 102 | |
| 9 | 2012 | 59 | |
| 10 | 2011 | 125 | |
| 11 | 2010 | 90 | |
| 12 | 2009 | 21 | |
| 13 | 2009 | 217 | |
| 14 | 2009 | 151 | |
| 15 | 2003 | 80 | |
| 16 | 2001 | 80 | |
| 17 | 2000 | 320 | |
| 18 | 1998 | 115 | |
| 19 | 1997 | 59 | |
| 20 | 1991 | 17 |
About Murray Korc
Murray Korc is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 370 papers that have together received 26.5k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (135 papers), TGF-β signaling in diseases (57 papers), Pancreatitis Pathology and Treatment (43 papers), Fibroblast Growth Factor Research (37 papers), Cancer Cells and Metastasis (35 papers), Pancreatic function and diabetes (34 papers), HER2/EGFR in Cancer Research (31 papers) and Metabolism, Diabetes, and Cancer (29 papers). The work is most often cited by research in Oncology (12.3k citations), Cancer Research (5.5k citations) and Molecular Biology (14.7k citations). Murray Korc has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Helmut Friess, Jörg Kleeff, Markus W. Büchler, Helmut Frieß, Yoichiro Yamanaka, Toshiyuki Ishiwata, Marko Kornmann, Michael S. Kobrin, Markus W. Büchler and Denis C. Guttridge. Their work appears in journals such as Pancreas, International Journal of Cancer, Cancer Research, Biochemical and Biophysical Research Communications and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.